Trial NCT01668654

View at ClinicalTrials.gov 
Org. Study IDs: 113388

Last trial update was posted on 2020-10-30

MeSH Interventions

Ezogabine

MeSH Conditions

Epilepsy Lennox Gastaut Syndrome

Other Conditions


Stopping Reasons

FDA placed a clinical hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.

Limitations And Caveats

This study was terminated early and only 4 of the planned 500 participants were enrolled. Due to the early study termination and small sample size, many planned analyses were not completed therefore lmiited results data were available.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID